About BioAccel
BioAccel, an accelerator and incubator program founded in 2009, is based in Phoenix, United States. With a presence in 1 country, it has supported around 12 startups in sectors like HealthTech, Life Sciences. As of Jul 2026, BioAccel has witnessed 1 portfolio exit. Most notable companies in
its portfolio include Wordpress, Life365 and Nasseo. The program is backed by a team of 6 people who primarily support Seed startups based in United States. Its latest investment was a $75K Seed round in TinyKicks on May 18, 2015.
Key Metrics
Founded Year
2009
Location
Phoenix, United States
Sectors of Investment
Stages of Investment
Seed & Grant (prize money)
Locations of Investment
BioAccel's List of Top Investments
BioAccel has a portfolio of 12 companies. Their most notable investments include Wordpress and Life365.Their portfolio spans across and United States. They have invested in HealthTech, Life Sciences, Enterprise Applications and 7 other sectors, across stages such as Seed, Grant (prize money) stages. Here is the list of top investments by BioAccel:
1. Wordpress
Provider of website hosting, domain name registration, and website building. It offers tools for creating websites, blogs, and online stores. Services include domain registration, website themes, and various plugins. The platform provides options for website design, email, and marketing.
Key facts about Wordpress
- Founded Year: 2005
- Location: United States
- Annual Revenue: £10M - £50M as on Dec 31, 2021
- Stage: Public
- Total Funding till date: $28K
- Employee Count: 1 as on May 31, 2026
- Investors: Orange, 8200 EISP and 11 Others
- Latest Funding Round: Seed, Nov 14, 2017, $*****
- Highlight: Public
_1580102973704.png?format=webp&height=120&width=120){kind=logo}
2. Life365
Provider of software and device for patient remote monitoring. The platform includes solutions for patients with various conditions where remote patient monitoring and active self-management. It gather biometric measurements, and other data, from patients located in their homes.
Key facts about Life365
- Founded Year: 2015
- Location: Scottsdale (United States)
- Stage: Series A
- Total Funding till date: $39M
- Employee Count: 14 as on Jun 30, 2026
- Investors: Arizona Commerce Authority, Mayo Clinic and 5 Others
- Latest Funding Round: Series A, Jul 01, 2026, $*****
3. Nasseo
Nasseo, Inc. is a medical device company that has developed next generation nanotube implant surface technology (“TiArray™”) that provides clinicians and patients with better dental and orthopedic implant treatment options. Nasseo’s TiArray™ nanotechnology alters the natural oxide layer of the implant material (Ti, Ta, Zi, CoCr, etc) to create a uniformed nanotube array surface that has shown stronger bonding, faster healing, anti-inflammatory, anti-bacterial, and soft tissue response benefits in over 10 years of pre-clinical R&D at UCSD. Nasseo’s first product, the TiArray™ Dental Implant, has received FDA approval and post-market human clinical trials will be conducted in 2014. Nasseo is also developing a second product which is a Titanium-PEEK hybrid interbody fusion device (spinal cage implant) that also integrates TiArray™ nanotechnology.
Key facts about Nasseo
- Founded Year: 2012
- Location: Peoria (United States)
- Stage: Series A
- Total Funding till date: $2.25M
- Investors: Baruch Future Ventures, Arizona Commerce Authority and 4 Others
- Latest Funding Round: Grant (prize money), Jul 01, 2016, $*****
4. TinyKicks
Fetal Kicks is a development phase product, its a flexible, wireless smart sensor that captures fetal movement with machine learning to predict and guide healthy pregnancy outcomes. As of October 2015 company is incubated at Evonexus.
Key facts about TinyKicks
- Founded Year: 2014
- Location: Irvine (United States)
- Stage: Seed
- Total Funding till date: $1.2M
- Employee Count: 11 - 50 as on Jul 01, 2024
- Investors: EvoNexus, Tech Coast Angels and 3 Others
- Latest Funding Round: Seed, Dec 28, 2016, $*****
- Highlight: Editors' Pick
Innovative NG/OG tube placement verification solutions improving patient safety. They are dedicated to eliminating harm from misplaced NG/OG tubes with their RightSpotpH® Indicator technology. This technology offers a fast, accurate, and radiation-free method for confirming tube placement, reducing misplacement risks and enhancing patient safety. Their solutions cater to various medical environments, including NICUs, ICUs/PICUs, and Emergency Departments, offering point-of-care testing. They champion pH testing as the primary method for confirmation, advocating against outdated auscultation practices. Their product line includes solutions for standard, small bore, and ENFit connections. They focus on improving patient outcomes and enhancing safety through reliable and easy-to-adopt solutions. They are committed to innovation and making a positive impact on healthcare professionals and patients.
Key facts about RightBio Metrics
- Founded Year: 2005
- Location: Peoria (United States)
- Stage: Series A
- Total Funding till date: $1.25M
- Employee Count: 3 as on May 31, 2026
- Investors: Arizona Commerce Authority, Alliance Healthcare Partners and 1 Other
- Latest Funding Round: Series A, Dec 29, 2016, $*****
- Highlight: Editors' Pick
BioAccel's Investments by Stage
BioAccel has made 3 investments in Seed stage with an average round size of $63.3K and 1 investment in Grant (prize money) stage with an average round size of $100K.Stage of entry | No. of Investments |
|---|---|
Seed | 3 |
Grant (prize money) | 1 |
Note: We have considered here, only first round of investments
BioAccel's Investments by Sector
BioAccel has a diverse portfolio, with companies operating in the HealthTech, Life Sciences, Consumer, Enterprise Applications and Healthcare. Notably, it has invested in 10 Tech companies, 7 Software companies, 6 Enterprise (B2B) companies and at least 4 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
HealthTech | 3 |
Life Sciences | 3 |
Consumer | 2 |
Enterprise Applications | 1 |
Healthcare | 1 |
Others | 5 |
Note: We have considered here, only first round of investments
BioAccel's Investments by Geography
BioAccel has made most investments in United States (4).BioAccel's recent investments
BioAccel has not made any investment in 2026 so far.Here are the most recent investments by BioAccel:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 18, 2015 | United States | Seed | 1944 | - | |
May 29, 2014 | United States | Seed | 6583 | - | |
Feb 06, 2014 | United States | Seed | 1579 | - | |
Jan 24, 2014 | United States | Grant (prize money) | 5354 | - |
IPOs and Publicly Listed companies in BioAccel's Portfolio
1 of BioAccel's portfolio company became public - Wordpress. It got listed on the Bombay Stock Exchange (BSE), in Oct 2009.Here are BioAccel's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 09, 2009 | - | - | 3502 |
Team profile of BioAccel
BioAccel has a team of 6 members including 4 Partners located in United States. BioAccel's team does not sit on the board of any company as of now.Here is a list of all team members in BioAccel:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Boston | - | ||
Partner | Phoenix | - | - | |
Partner | Phoenix | - | - | |
Partner | - | - | - |
Co-investors of BioAccel
Over the past 12 years, 2 investors have co-invested in BioAccel's portfolio companies. This includes funds and angels.
